Pharma Journalist -

Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, announced a strategic collaboration with…
Read More...

Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat cancers, announced that the U.S. Food…
Read More...

Agastiya Biotech and Vopec Pharmaceuticals announce that the US FDA has granted Orphan Drug Designations for Pancreatic Cancer and AML for its novel small molecule, AB001. AB001 is a…
Read More...

Brickell Biotech, Inc. a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the…
Read More...

STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies targeting RNA epigenetic mechanisms, announces that it has been awarded a Biomedical…
Read More...

Genesis Therapeutics, a company pioneering artificial intelligence technologies to create medicines for patients with severe and unmet medical conditions, announced that it has entered…
Read More...

Nicoya Lifesciences, a global innovator of digital proteomics solutions for diagnostics and biotherapeutic discovery, announced the acquisition of LSK Technologies, a University of…
Read More...

Endo International plc announced that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables…
Read More...

Horizon Therapeutics plc announced the European Commission (EC) approval of UPLIZNA (inebilizumab) as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum…
Read More...

Supernus Pharmaceuticals, Inc. a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced that…
Read More...